Notice of Intent to Publish a Funding Opportunity Announcement for Trailblazer Award for New and Early-Stage Investigators (R21 Clinical Trial Optional)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health (NIH), through the National Institute of Biomedical Imaging and Bioengineering in collaboration with several other institutes including the National Eye Institute and the National Cancer Institute, plans to issue a Notice of Funding Opportunity (NOFO) for the Trailblazer Award. This award targets New and Early Stage Investigators defined by NIH, encouraging research that integrates engineering and physical sciences with life and biomedical sciences. The award supports a broad range of projects including exploratory, developmental, proof-of-concept, and high-risk high-impact studies, that may be driven by technology design, discovery, or specific hypotheses. Applicants with expertise in engineering and quantitative sciences such as physics, mathematics, chemistry, and computer science are particularly encouraged to prepare for submission under the R21 activity code. Collaborative, trans-disciplinary research projects that could open new avenues in biomedical investigation are also highly encouraged. Although applications are not currently being solicited, this notice provides advance information to allow potential applicants sufficient time to develop appropriate collaborations and responsive projects. The point of contact for this initiative is Randy King at the National Institute of Biomedical Imaging and Bioengineering.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Institute of Biomedical Imaging and Bioengineering, with the National Eye Institute, the National Institute on Aging, the National Cancer Institute, and the National Center for Complementary and Integrative Health intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the Trailblazer Award. This is an opportunity for NIH-defined New and Early Stage Investigators (https://grants.nih.gov/policy/early-investigators/index.htm) to pursue research programs that integrate engineering and the physical sciences with the life and/or biomedical sciences. A Trailblazer project may be exploratory, developmental, proof of concept, or high-risk high-impact, and may be technology design-directed, discovery-driven, or hypothesis-driven. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the R21 activity code. Investigators with expertise and insights into the application of principles and techniques from engineering and quantitative sciences, such as physics, mathematics, chemistry, and computer sciences are encouraged to begin to consider applying for this new NOFO. In addition, collaborative investigations combining expertise in trans-disciplinary research approaches with the potential to open new areas of biomedical investigation will be encouraged and these investigators should also begin considering applying for this application.
